Parker Bohm, MD
Neuro-ophthalmology · Wichita, KSNPI 1598299935
Payments from drug & device makers
Across 17 payments — averaging $26.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$65
- Lundbeck LLC$58
- Globus Medical$55
- Eisai Inc.$50
- Merz Pharmaceuticals, LLC$34
- Johnson & Johnson$29
- plus $168 from 10 others
What the payments were for
- Food & beverage$458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 1 | $65 |
| Lundbeck LLC | 2 | $58 |
| Globus Medical | 1 | $55 |
| Eisai Inc. | 1 | $50 |
| Merz Pharmaceuticals, LLC | 1 | $34 |
| Johnson & Johnson | 1 | $29 |
| Bristol Myers Squibb | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Banner Life Sciences, LLC | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| TG Therapeutics, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Amylyx Pharmaceuticals, Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| GE HealthCare | 1 | $13 |
How this compares
Too few neuro-ophthalmology providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 14 | $24,004 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $19,593 |
| Emgality PenGalcanezumab-Gnlm | 22 | $16,128 |
| UbrelvyUbrogepant | 13 | $15,724 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $10,737 |
| Gabapentin | 325 | $5,452 |
| Lamotrigine ErLamotrigine | 20 | $5,284 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 220 | $4,414 |
| Lacosamide | 28 | $4,066 |
| Pyridostigmine Bromide | 33 | $3,442 |
| FingolimodFingolimod Hcl | 13 | $2,756 |
| Memantine Hcl | 164 | $2,573 |
| Levetiracetam | 95 | $2,029 |
| Propranolol Hcl | 46 | $1,556 |
| Oxcarbazepine | 40 | $1,408 |
Paid to pharmacies, not to this prescriber.
Other neuro-ophthalmology in Wichita
- Sean GrattonLeawood$1K
- Sara KrachmalnickPrairie Village$513
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.